Cargando…
Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
BACKGROUND: The aim of this study was to translate the EORTC quality of life questionnaire for brain cancer, the QLQ-BN20, into Persian, and to evaluate its psychometric properties when used among brain cancer patients in Iran. METHODS: A standard backward and forward translation procedure was used...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422187/ https://www.ncbi.nlm.nih.gov/pubmed/22607028 http://dx.doi.org/10.1186/1477-7525-10-54 |
_version_ | 1782241007662792704 |
---|---|
author | Khoshnevisan, Alireza Yekaninejad, Mir Saeed Ardakani, Shahab Kamali Pakpour, Amir H Mardani, Azam Aaronson, Neil K |
author_facet | Khoshnevisan, Alireza Yekaninejad, Mir Saeed Ardakani, Shahab Kamali Pakpour, Amir H Mardani, Azam Aaronson, Neil K |
author_sort | Khoshnevisan, Alireza |
collection | PubMed |
description | BACKGROUND: The aim of this study was to translate the EORTC quality of life questionnaire for brain cancer, the QLQ-BN20, into Persian, and to evaluate its psychometric properties when used among brain cancer patients in Iran. METHODS: A standard backward and forward translation procedure was used to generate the Persian language version of the QLQ-BN20. The QLQ-BN20 was administered together with the QLQ-C30 to 194 patients diagnosed with primary brain cancer. Multitrait scaling and confirmatory factor analysis (CFA) were used to evaluate the hypothesized scale structure of the questionnaire. Internal consistency reliability was estimated with Cronbach’s alpha. The ability of the QLQ-BN20 to distinguish between patient subgroups formed on the basis of performance status and cognitive status was evaluated, as was the responsiveness of the questionnaire to changes in performance status over time. RESULTS: Multitrait scaling and CFA results confirmed the hypothesized scale structure. The measurement model was consistent across men and women. Internal consistency reliability of the multi-item scales ranged from 0.74 to 0.89. The QLQ-BN20 distinguished clearly between patients with relatively good versus poor performance and cognitive status, and changes in scores over time reflected changes observed in performance status ratings. CONCLUSIONS: These results support the validity and reliability of the QLQ-BN20 for use among Iranian patients diagnosed with primary brain cancer. Future studies should examine the psychometrics of the questionnaire when used in patients with brain metastasis. |
format | Online Article Text |
id | pubmed-3422187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34221872012-08-18 Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran Khoshnevisan, Alireza Yekaninejad, Mir Saeed Ardakani, Shahab Kamali Pakpour, Amir H Mardani, Azam Aaronson, Neil K Health Qual Life Outcomes Research BACKGROUND: The aim of this study was to translate the EORTC quality of life questionnaire for brain cancer, the QLQ-BN20, into Persian, and to evaluate its psychometric properties when used among brain cancer patients in Iran. METHODS: A standard backward and forward translation procedure was used to generate the Persian language version of the QLQ-BN20. The QLQ-BN20 was administered together with the QLQ-C30 to 194 patients diagnosed with primary brain cancer. Multitrait scaling and confirmatory factor analysis (CFA) were used to evaluate the hypothesized scale structure of the questionnaire. Internal consistency reliability was estimated with Cronbach’s alpha. The ability of the QLQ-BN20 to distinguish between patient subgroups formed on the basis of performance status and cognitive status was evaluated, as was the responsiveness of the questionnaire to changes in performance status over time. RESULTS: Multitrait scaling and CFA results confirmed the hypothesized scale structure. The measurement model was consistent across men and women. Internal consistency reliability of the multi-item scales ranged from 0.74 to 0.89. The QLQ-BN20 distinguished clearly between patients with relatively good versus poor performance and cognitive status, and changes in scores over time reflected changes observed in performance status ratings. CONCLUSIONS: These results support the validity and reliability of the QLQ-BN20 for use among Iranian patients diagnosed with primary brain cancer. Future studies should examine the psychometrics of the questionnaire when used in patients with brain metastasis. BioMed Central 2012-05-20 /pmc/articles/PMC3422187/ /pubmed/22607028 http://dx.doi.org/10.1186/1477-7525-10-54 Text en Copyright ©2012 Khoshnevisan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Khoshnevisan, Alireza Yekaninejad, Mir Saeed Ardakani, Shahab Kamali Pakpour, Amir H Mardani, Azam Aaronson, Neil K Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran |
title | Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran |
title_full | Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran |
title_fullStr | Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran |
title_full_unstemmed | Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran |
title_short | Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran |
title_sort | translation and validation of the eortc brain cancer module (eortc qlq-bn20) for use in iran |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422187/ https://www.ncbi.nlm.nih.gov/pubmed/22607028 http://dx.doi.org/10.1186/1477-7525-10-54 |
work_keys_str_mv | AT khoshnevisanalireza translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran AT yekaninejadmirsaeed translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran AT ardakanishahabkamali translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran AT pakpouramirh translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran AT mardaniazam translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran AT aaronsonneilk translationandvalidationoftheeortcbraincancermoduleeortcqlqbn20foruseiniran |